September 6, 2023 11:21 AM EDT
News Briefing

Mer­sana CEO to step down af­ter eight years; Roy­al­ty Phar­ma pays $150M for Skytro­fa roy­al­ties

Tyler Patchen

News Reporter

Paul Schloesser

Associate Editor

Mer­sana Ther­a­peu­tics said Wednes­day that pres­i­dent and CEO An­na Pro­topa­pas is re­tir­ing Sept. 10, and board mem­ber Mar­tin Hu­ber will take …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA says Ozem­pic, We­govy short­age is over

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times